Veeva Systems Inc. (NYSE: VEEV), a leader in cloud solutions for the life sciences sector, announced its impressive fourth quarter and fiscal year 2025 results, demonstrating substantial growth across all key financial metrics. The financial performance reflects Veeva's commitment to delivering innovative solutions that enhance the efficiency of life sciences companies in delivering better treatments to patients.

Fourth Quarter Highlights

Revenue Growth: Veeva reported total revenues of $720.9 million in Q4, marking a 14% increase from $630.6 million in the same quarter last year. Subscription services revenues also saw a significant rise, reaching $608.6 million, up 17% from $521.5 million year-over-year.

Operating Income: The company’s operating income for the fourth quarter surged to $188.4 million, representing a 39% increase compared to $135.3 million in Q4 of the previous year. Non-GAAP operating income also rose by 29% to $307.7 million from $239.1 million.

Net Income: Veeva’s net income in Q4 reached $195.6 million, a 33% increase from $147.4 million a year ago. Non-GAAP net income climbed to $287.9 million, marking a 27% year-over-year growth.

Earnings Per Share: For the fourth quarter, fully diluted net income per share increased to $1.18, up from $0.90, while non-GAAP fully diluted net income per share rose to $1.74, compared to $1.38 in the previous year.

Fiscal Year 2025 Performance

Veeva's fiscal year results were equally impressive, showcasing a robust year of performance:

Total Revenues: For the fiscal year ending January 31, 2025, Veeva reported total revenues of $2,746.6 million, a 16% increase from $2,363.7 million in fiscal 2024. Subscription services revenues increased by 20% to $2,284.7 million from $1,901.6 million.

Operating Income: The company's operating income for the fiscal year was $691.4 million, up 61% from $429.3 million in the previous year. Non-GAAP operating income rose 37% to $1,152.3 million from $842.5 million.

Net Income: Veeva’s net income for the fiscal year reached $714.1 million, a 36% increase from $525.7 million a year earlier. Non-GAAP net income also rose by 38% to $1,090.4 million from $791.0 million.

Earnings Per Share: Fully diluted net income per share for the fiscal year was $4.32, up from $3.22 the previous year, while non-GAAP fully diluted net income per share increased to $6.60 from $4.84.

Strategic Insights from Leadership

CEO Peter Gassner expressed his enthusiasm about Veeva's achievements, stating, "It was an outstanding quarter and year of execution and innovation in software, data, and business consulting." He emphasized the company’s commitment to aiding life sciences in delivering better treatments more efficiently.

CFO Brian Van Wagener added, "We closed the year with results ahead of guidance for all metrics. Our execution continues to be strong, and we see momentum across our product areas."

Recent Highlights and Innovations

Veeva has made significant strides in building its industry cloud for life sciences through:

Customer Expansion: Veeva concluded the year with 1,477 customers, including 1,125 in Veeva R&D Solutions and 730 in Veeva Commercial Solutions, indicating strong demand across all customer segments.

Vault CRM Innovations: The launch of Vault CRM, which features enhanced capabilities and an upcoming AI integration, underscores Veeva's dedication to innovation in customer relationship management.

Quality Cloud Success: The Quality Cloud platform saw the addition of 41 new customers and expansion among existing clients, reinforcing Veeva's status as a standard for drug development and quality in the sector.

Financial Outlook

Looking ahead, Veeva provided guidance for its fiscal first quarter ending April 30, 2025, anticipating total revenues between $726 and $729 million and a non-GAAP operating income between $307 and $309 million. For the fiscal year ending January 31, 2026, Veeva expects total revenues to be between $3,040 and $3,055 million, with a non-GAAP operating income of approximately $1,300 million.

Conclusion

Veeva Systems Inc. has positioned itself as a formidable player in the life sciences industry, showcasing strong financial performance and a commitment to innovation. As the company continues to expand its customer base and enhance its product offerings, it appears well-equipped to meet the evolving needs of the life sciences sector in the years to come.

For more insights, Veeva will host a Q&A conference call at 2:00 p.m. PT today, March 5, 2025, where further discussion on these results will take place.

Original press release